Backgrounds: Both pretreatment serum CRP (C-reactive protein) level and ALB (albumin) level have been found to be predictive of survival for multiple malignancies including sarcoma. Since both of the GPS (Glasgow prognostic score) and CAR (C-reactive protein to albumin ratio) are based on the combination of CRP and ALB, we conducted a meta-analysis to evaluate the prognostic role of these two parameters for sarcoma patients.
Methods: A detailed literature search was conducted in MEDLINE, Embase, and Cochrane Library for relevant research publications written in English. Patients' clinical characteristics, outcomes of overall survival (OS), disease-specific survival (DSS), and disease-free survival (DFS) were extracted. Pooled hazard ratios (HRs) and corresponding 95% confidence intervals (CIs) were combined to evaluate the prognostic role of GPS or CAR.
Results: Twelve articles containing 2695 patients were identified as eligible studies. The results showed that an elevated GPS was significantly correlated with poor OS (HR = 2.42; 95% CI: 1.98-2.94; p < 0.001; fixed-effects model), DSS (HR = 2.28; 95% CI: 1.75-2.97; p < 0.001; fixed-effects model), DSS (HR = 2.28; 95% CI: 1.75-2.97; p < 0.001; fixed-effects model), DSS (HR = 2.28; 95% CI: 1.75-2.97; p < 0.001; fixed-effects model), DSS (HR = 2.28; 95% CI: 1.75-2.97; p < 0.001; fixed-effects model), DSS (HR = 2.28; 95% CI: 1.75-2.97.
Conclusion: An elevated GPS is predictive of poor survival in patients with sarcomas and is promising to be used as a factor for risk stratification. A higher CAR value is also predictive of poor survival; however, the optimal CAR cut-off value is still to be determined.
Copyright © 2020 Erhu Fang et al.
Conflict of interest statement
The authors declare that there is no conflict of interest regarding the publication of this paper.
The value of C-reactive protein as an independent prognostic indicator for disease-specific survival in patients with soft tissue sarcoma: A meta-analysis.PLoS One. 2019 Jul 1;14(7):e0219215. doi: 10.1371/journal.pone.0219215. eCollection 2019. PLoS One. 2019. PMID: 31260491 Free PMC article.
Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis.Ann Transl Med. 2019 Oct;7(20):531. doi: 10.21037/atm.2019.09.160. Ann Transl Med. 2019. PMID: 31807513 Free PMC article.
Prognostic significance of C-reactive protein to albumin ratio in colorectal cancer patients: a meta-analysis.Int J Colorectal Dis. 2019 Jun;34(6):1105-1111. doi: 10.1007/s00384-019-03299-x. Epub 2019 Apr 23. Int J Colorectal Dis. 2019. PMID: 31016379
The prognostic value of C-reactive protein/albumin ratio in human malignancies: an updated meta-analysis.Onco Targets Ther. 2017 Jun 19;10:3059-3070. doi: 10.2147/OTT.S137002. eCollection 2017. Onco Targets Ther. 2017. PMID: 28790840 Free PMC article. Review.
Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.Cancer Biomark. 2016;16(3):333-42. doi: 10.3233/CBM-160571. Cancer Biomark. 2016. PMID: 26835589 Review.